Cuprina Holdings (Cayman) Limited Class A (CUPR)
NASDAQ:CUPR
Want to see CUPR full AI Analyst Report?
CUPR Stock Chart & Stats
$0.38
--
Market closed
$0.38
--
Day’s Range― - ―
52-Week Range$1.76 - $76.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.90M
Market Cap
$2.04M
Enterprise Value$7.89M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.05
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding920,625
10 Day Avg. Volume197,362
30 Day Avg. Volume2,899,437
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.08
Price to Sales (P/S)211.01
P/FCF Ratio-1.15
Enterprise Value/Market Cap3.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
SFDA Classification For MEDIFLY In Saudi ArabiaRegulatory classification as a Medical Device–Drug combination enables formal commercial distribution across Saudi Arabia’s healthcare network. This materially improves market access and revenue runway in MENA, supporting a durable commercial pathway and regional scale-up potential over months.
Low Absolute Leverage / Modest Debt LevelsRelatively modest debt reduces immediate refinancing pressure and gives management time to execute commercialization or financing plans. Lower leverage enhances liquidity flexibility and reduces bankruptcy risk, a structural advantage while the company pursues revenue generation.
Shareholder-approved Capital Reorganization And Financing FlexibilityConsolidation and expanded authorized capital legally enable future equity raises and share-structure adjustments. This structural flexibility increases the company's ability to secure financing, support operations or fund commercialization without needing new charter amendments.
Bears Say
Dramatically Rising Cash Burn And Persistent Negative Cash FlowConsistent negative operating cash flow and a sharp 2025 increase in burn create ongoing funding risk and likely near-term dilution or financing needs. This structurally weak cash generation undermines independence and raises execution risk over the coming months.
Small, Volatile Revenue And Deteriorating ProfitabilityVolatile, low revenue and a swing to negative gross profit indicate limited product-market traction and weak operating leverage. Persistent losses constrain reinvestment and require outsized external funding, limiting sustainable margin improvements in the medium term.
Governance Entrenchment Via Enhanced Class B VotingA structural shift that concentrates voting power reduces minority shareholder influence and raises governance risk. Entrenched control can limit oversight, increase the chance of shareholder-unfriendly financings, and affect long-term strategic accountability.
Cuprina Holdings (Cayman) Limited Class A News
CUPR FAQ
What was Cuprina Holdings (Cayman) Limited Class A’s price range in the past 12 months?
Cuprina Holdings (Cayman) Limited Class A lowest stock price was $1.76 and its highest was $76.00 in the past 12 months.
What is Cuprina Holdings (Cayman) Limited Class A’s market cap?
Cuprina Holdings (Cayman) Limited Class A’s market cap is $2.04M.
When is Cuprina Holdings (Cayman) Limited Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cuprina Holdings (Cayman) Limited Class A’s earnings last quarter?
Currently, no data Available
Is Cuprina Holdings (Cayman) Limited Class A overvalued?
According to Wall Street analysts Cuprina Holdings (Cayman) Limited Class A’s price is currently Overvalued.
Does Cuprina Holdings (Cayman) Limited Class A pay dividends?
Cuprina Holdings (Cayman) Limited Class A does not currently pay dividends.
What is Cuprina Holdings (Cayman) Limited Class A’s EPS estimate?
Cuprina Holdings (Cayman) Limited Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cuprina Holdings (Cayman) Limited Class A have?
Cuprina Holdings (Cayman) Limited Class A has 920,625 shares outstanding.
What happened to Cuprina Holdings (Cayman) Limited Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cuprina Holdings (Cayman) Limited Class A?
Currently, no hedge funds are holding shares in CUPR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cuprina Holdings (Cayman) Limited Class A
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.
Technical Analysis
GeoVax Labs
―
HCW Biologics
―
Calidi Biotherapeutics
―
Psyence Biomedical
―
Aspire Biopharma Holdings
―
Ownership Overview
―
Insiders
0.17% Mutual Funds
1.66% Other Institutional Investors
98.16% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---